Page 41 - JCBP-2-1

Journal of Clinical and
Basic Psychosomatics The endocannabinoid system

https://doi.org/10.1515/jbcpp-2020-0279 https://doi.org/10.31887/dcns.2020.22.3/rspanagel
106. Stachowicz K, 2023, Deciphering the mechanisms of 117. Maldonado R, Cabañero D, Martín-García E, 2020, The
reciprocal regulation or interdependence at the cannabinoid endocannabinoid system in modulating fear, anxiety, and
CB1 receptors and cyclooxygenase-2 level: Effects on mood, stress . Dialogues Clin Neurosci, 22: 229–239.
cognitive implications, and synaptic signaling. Neurosci https://doi.org/10.31887/DCNS.2020.22.3/rmaldonado
Biobehav Rev, 155: 105439.
118. Morena M, Patel S, Bains JS, et al., 2016, Neurobiological
https://doi.org/10.1016/j.neubiorev.2023.105439
interactions between stress and the endocannabinoid
107. Lu HC, Mackie K, 2020, Review of the endocannabinoid system. Neuropsychopharmacology, 41: 80–102.
system. Biol Psychiatry Cogn Neurosci Neuroimaging, 6: https://doi.org/10.1038/npp.2015.166
607–615.
119. Worley NB, Hill MN, Christianson JP, 2018, Prefrontal
https://doi.org/10.1016/j.bpsc.2020.07.016
endocannabinoids, stress controllability and resilience:
108. Joshi N, Onaivi ES, 2019, Endocannabinoid system A hypothesis. Prog Neuropsychopharmacol Biol Psychiatry,
components: Overview and tissue distribution. Adv Exp 85: 180–188.
Med Biol, 1162: 1–12.
https://doi.org/10.1016/j.pnpbp.2017.04.004
https://doi.org/10.1007/978-3-030-21737-2_1
120. Brunt TM, Bossong MG, 2022, The neuropharmacology of
109. Mueller B, Figueroa A, Robinson-Papp J, 2022, Structural cannabinoid receptor ligands in central signaling pathways.
and functional connections between the autonomic Eur J Neurosci, 55: 909–921.
nervous system, hypothalamic-pituitary-adrenal axis, and https://doi.org/10.1111/ejn.14982
the immune system: A context and time dependent stress
response network. Neurol Sci, 43: 951–960. 121. Chadwick VL, Rohleder C, Koethe D, et al., 2020,
Cannabinoids and the endocannabinoid system in anxiety,
https://doi.org/10.1007/s10072-021-05810-1
depression, and dysregulation of emotion in humans. Curr
110. Bernal-Chico A, Tepavcevic V, Manterola A, et al., 2023, Opin Psychiatry, 33: 20–42.
Endocannabinoid signaling in brain diseases: Emerging https://doi.org/10.1097/yco.0000000000000562
relevance of glial cells. Glia, 71: 103–126.
122. Mayo LM, Rabinak CA, Hill MN, et al., 2021, Targeting the
https://doi.org/10.1002/glia.24172
endocannabinoid system in the treatment of posttraumatic
111. Paloczi J, Varga ZV, Hasko G, et al., 2018, Neuroprotection stress disorder: A promising case of preclinical-clinical
in oxidative stress-related neurodegenerative diseases: Role translation? Biol Psychiatry, 91: 262–272.
of endocannabinoid system modulation. Antioxid Redox https://doi.org/10.1016/j.biopsych.2021.07.019
Signal, 29: 75–108.
123. Kasatkina LA, Rittchen S, Sturm EM, 2021, Neuroprotective
https://doi.org/10.1089/ars.2017.7144
and immunomodulatory action of the endocannabinoid
112. Kasatkina LA, Rittchen S, Sturm EM, 2021, Neuroprotective system under neuroinflammation. Int J Mol Sci, 22:
and immunomodulatory action of the endocannabinoid 5431–5431.
system under neuroinflammation. Int J Mol Sci, 22: 5431.
https://doi.org/10.3390/ijms22115431
https://doi.org/10.3390/ijms22115431
124. Almogi-Hazan O, Or R, 2020, Cannabis, the
113. Hillard CJ, 2015, The endocannabinoid signaling system in endocannabinoid system and immunity-the journey from
the CNS: A primer. Int Rev Neurobiol, 125: 1–47. the bedside to the bench and back. Int J Mol Sci, 21: 4448.
https://doi.org/10.1016/bs.irn.2015.10.001 https://doi.org/10.3390/ijms21124448
114. Gregus AM, Buczynski MW, 2020, Druggable targets 125. Aziz A, Nguyen LC, Oumeslakht L, et al., 2022,
in endocannabinoid signaling. Adv Exp Med Biol, 1274: Cannabinoids as immune system modulators: Cannabidiol
177–201. potential therapeutic approaches and limitations. Cannabis
Cannabinoid Res, 8: 254–269.
https://doi.org/10.1007/978-3-030-50621-6_8
https://doi.org/10.1089/can.2022.0133
115. Kilaru A, Chapman KD, 2020, The endocannabinoid system.
Essays Biochem, 64: 485–499. 126. Yue Y, Li L, Li R, et al., 2023, The dynamic changes of
psychosomatic symptoms in three waves of COVID-19
https://doi.org/10.1042/ebc20190086
outbreak and fatigue caused by enduring pandemic in
116. Spanagel R, 2020, Cannabinoids and the endocannabinoid China. J Affect Disord, 331: 17–24.
system in reward processing and addiction: From
mechanisms to interventions. Dialogues Clin Neurosci, https://doi.org/10.1016/j.jad.2023.03.032
22: 241–250. 127. Braile M, Marcella S, Marone G, et al., 2021, The interplay

Volume 2 Issue 1 (2024) 17 https://doi.org/10.36922/jcbp.2288